Clinical trial researching therapy for recurrent respiratory papillomatosis

Recurrent Respiratory Papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. These growths can be removed by surgery but typically grow back. A clinical trial led by Scott M. Norberg, D.O., Assistant Research Physician in the Center for Immuno-Oncology, is researching a drug therapy for RRP. The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.

For more information, please contact Amy Lankford, Ph.D., at (301) 556-9900 or clinicaltrials@precigen.com

Clinicaltrials.gov identifier: NCT04724980

NCI Protocol ID: 21-C-0013

Official Title: A Phase I/II Study of Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis